Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke: a Prospective, Random, Blinded Assessment of Outcome and Open Label Multi-center Study

NCT03661411 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.

NCT NCT03661411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03661411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiplatelet vs R-tPA for Acute Mild Ischemic Stroke: a Prospective, Random, Blinded Assessment of Outcome and Open Label Multi-center Study
Lead sponsor
General Hospital of Shenyang Military Region
Phase
Phase 4
Overall status
Completed
Start date
October 17, 2018
Completion date
July 18, 2022
Enrollment
760 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke